Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer

NCT06468215 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT06468215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06468215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 21, 2024
Completion date
October 31, 2028
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, endometrioid, fertility preservation